Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53

Yoshinori Uchihara, Keiji Tasaka, Takashi Mikami, Yosuke Yamada, Hiroaki Ito, Hajime Okita, Ryunosuke Tojo, Ryo Akazawa, Kiyotaka Isobe, Tatsuya Kamitori, Masahiko Nishitani-Isa, Hirohito Kubota, Satoshi Saida, Itaru Kato, Tatsuya Okamoto, Eri Ogawa, Hideaki Okajima, Yukichi Tanaka, Takako Yoshioka, Nobuyuki Kakiuchi, Yuichi Shiraishi, Tetsuya Takimoto, Shugo Komatsu, Mitsutaka Shiota, Kazuko Kudo, Hiroyuki Fujisaki, Masahiro Sekiguchi, Yoshiyuki Takahashi, Mamoru Ito, Tatsutoshi Nakahata, Hironori Haga, Eiso Hiyama, Seishi Ogawa, Katsutsugu Umeda, Junko Takita

Open source

DOI
10.1038/s41698-026-01563-2
Published
2026-07-14
Container
npj Precision Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41698-026-01563-2,
  title = {Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53},
  author = {Yoshinori Uchihara and Keiji Tasaka and Takashi Mikami and Yosuke Yamada and Hiroaki Ito and Hajime Okita and Ryunosuke Tojo and Ryo Akazawa and Kiyotaka Isobe and Tatsuya Kamitori and Masahiko Nishitani-Isa and Hirohito Kubota and Satoshi Saida and Itaru Kato and Tatsuya Okamoto and Eri Ogawa and Hideaki Okajima and Yukichi Tanaka and Takako Yoshioka and Nobuyuki Kakiuchi and Yuichi Shiraishi and Tetsuya Takimoto and Shugo Komatsu and Mitsutaka Shiota and Kazuko Kudo and Hiroyuki Fujisaki and Masahiro Sekiguchi and Yoshiyuki Takahashi and Mamoru Ito and Tatsutoshi Nakahata and Hironori Haga and Eiso Hiyama and Seishi Ogawa and Katsutsugu Umeda and Junko Takita},
  year = {2026},
  journal = {npj Precision Oncology},
  doi = {10.1038/s41698-026-01563-2},
  url = {https://doi.org/10.1038/s41698-026-01563-2}
}

RIS

TY  - JOUR
TI  - Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53
AU  - Yoshinori Uchihara
AU  - Keiji Tasaka
AU  - Takashi Mikami
AU  - Yosuke Yamada
AU  - Hiroaki Ito
AU  - Hajime Okita
AU  - Ryunosuke Tojo
AU  - Ryo Akazawa
AU  - Kiyotaka Isobe
AU  - Tatsuya Kamitori
AU  - Masahiko Nishitani-Isa
AU  - Hirohito Kubota
AU  - Satoshi Saida
AU  - Itaru Kato
AU  - Tatsuya Okamoto
AU  - Eri Ogawa
AU  - Hideaki Okajima
AU  - Yukichi Tanaka
AU  - Takako Yoshioka
AU  - Nobuyuki Kakiuchi
AU  - Yuichi Shiraishi
AU  - Tetsuya Takimoto
AU  - Shugo Komatsu
AU  - Mitsutaka Shiota
AU  - Kazuko Kudo
AU  - Hiroyuki Fujisaki
AU  - Masahiro Sekiguchi
AU  - Yoshiyuki Takahashi
AU  - Mamoru Ito
AU  - Tatsutoshi Nakahata
AU  - Hironori Haga
AU  - Eiso Hiyama
AU  - Seishi Ogawa
AU  - Katsutsugu Umeda
AU  - Junko Takita
PY  - 2026
JO  - npj Precision Oncology
DO  - 10.1038/s41698-026-01563-2
UR  - https://doi.org/10.1038/s41698-026-01563-2
ER  - 

APA

Uchihara, Y., Tasaka, K., Mikami, T., Yamada, Y., Ito, H., Okita, H., Tojo, R., Akazawa, R., Isobe, K., Kamitori, T., Nishitani-Isa, M., Kubota, H., Saida, S., Kato, I., Okamoto, T., Ogawa, E., Okajima, H., Tanaka, Y., Yoshioka, T., Kakiuchi, N., Shiraishi, Y., Takimoto, T., Komatsu, S., Shiota, M., Kudo, K., Fujisaki, H., Sekiguchi, M., Takahashi, Y., Ito, M., Nakahata, T., Haga, H., Hiyama, E., Ogawa, S., Umeda, K., & Takita, J. (2026). Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01563-2

Source records